Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants
Tommy Tsang Cheung,1,* Tu H Mai,2,* Yen Lin Chia,2 Desmond YH Yap,1 Chi-Ho Lee,1 Cecil Chi-Keung Chen,2 Ying Huang,3 Yuwen Jin,3 James Johnston,4 Viktoria Werkström,5 Yuhui Yao,6 Xiaoyun Ge,7 Wenying Zheng8 1Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Ho...
Main Authors: | Cheung TT, Mai TH, Chia YL, Yap DYH, Lee CH, Chen CC, Huang Y, Jin Y, Johnston J, Werkström V, Yao Y, Ge X, Zheng W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/safety-tolerability-and-pharmacokinetics-of-benralizumab-a-phase-1-ran-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Successful Introduction of Benralizumab for Eosinophilic Ascites
by: Nabil Belfeki, et al.
Published: (2024-01-01) -
Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
by: Singh D, et al.
Published: (2023-07-01) -
Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumab
by: Rory Chan, MBChB, PhD, et al.
Published: (2023-08-01) -
Benralizumab: eficacia y seguridad en pacientes con asma grave eosinofílica.
by: Genny Chaia, et al.
Published: (2020-12-01) -
Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis
by: Osamu Matsuno, et al.
Published: (2022-01-01)